文献速递精神分裂症与精神病性障碍儿童青少年精神

精神分裂症中α7烟碱型乙酰胆碱受体、活化胶质细胞与认知损害的双示踪PET研究

α7 nicotinic acetylcholine receptor, activated glia, and cognitive impairment in schizophrenia: a dual-tracer PET study.
PubMed 文献 · Mol Psychiatry · 2025-08-19

全脑分析显示患者右侧小脑、海马旁区、壳核和枕叶皮层α7 nAChR可用性显著升高,TSPO水平组间无差异;患者中α7 nAChR可用性升高与TSPO水平及字母流畅性表现显著正相关,右侧海马旁区存在重叠。

要点

  • 精神分裂症患者右侧小脑、海马旁区、壳核和枕叶皮层α7 nAChR可用性显著升高。
  • 患者TSPO水平与健康对照无显著差异,但α7 nAChR可用性与TSPO水平显著正相关。
  • 右侧海马旁区α7 nAChR升高区与活化胶质细胞及认知功能障碍相关区重叠。

核心结论

  • 精神分裂症患者多个脑区α7 nAChR可用性升高,且与活化胶质细胞标志TSPO水平及字母流畅性表现正相关,α7 nAChR可能成为认知功能障碍的潜在治疗靶点。

主要发现

  • 全脑分析显示精神分裂症患者右侧小脑、海马旁区、壳核和枕叶皮层α7 nAChR可用性显著高于健康对照。
  • TSPO水平在精神分裂症患者与健康对照之间无显著差异。
  • 在精神分裂症组中,多个主要位于右侧半球的脑区α7 nAChR可用性升高与TSPO水平及字母流畅性表现显著正相关。
  • 右侧海马旁区中α7 nAChR可用性显著升高区域与活化胶质细胞及认知功能障碍显著相关区域存在重叠。

临床怎么用

  • α7 nAChR可用性升高与活化胶质细胞及字母流畅性表现相关,提示其或可作为精神分裂症认知功能障碍的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The α7 nicotinic acetylcholine receptor (nAChR) plays a crucial role in cognitive function, and its dysfunction has been proposed as a primary pathophysiological factor in schizophrenia. Although the α7 nAChR is expressed in both neuronal and activated glial cells, its association with activated glia and its role in the pathophysiology of schizophrenia remain uncertain. Therefore, we investigated α7 nAChR availability and activated glia evaluated with 18 kDa translocator protein (TSPO) levels in individuals with schizophrenia, and further examined their association and relationships to cognitive impairment. Nineteen individuals with schizophrenia, no smoking history or use of anticholinergic or benzodiazepine medications for at least 6 months, and 20 age- and sex-matched healthy controls underwent [11C](R)-MeQAA and [11C]DPA713 positron emission tomography scans on the same day. Whole-brain analyses revealed significantly higher α7 nAChR availability in the right cerebellum, perihippocampal region, putamen, and occipital cortex in individuals with schizophrenia. In line with previous findings, TSPO levels did not differ between groups. Furthermore, in the schizophrenia group, elevated α7 nAChR availability was significantly positively correlated with TSPO levels and letter fluency performance in various brain regions predominantly in the right hemisphere. Notably, in the right perihippocampal region, there was an overlap in regions showing a significantly higher α7 nAChR availability and regions significantly correlated with activated glia and cognitive dysfunction. Our findings provide novel insights into the role of the α7 nAChR and its association with activated glia in schizophrenia, and the α7 nAChR may serve as a potential therapeutic target for cognitive dysfunction.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Wakuda T, Yokokura M, Magata Y, et al. α7 nicotinic acetylcholine receptor, activated glia, and cognitive impairment in schizophrenia: a dual-tracer PET study. Mol Psychiatry. 2025. PMID: 40830578. doi:10.1038/s41380-025-03162-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。